Open AccessModulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab
Author(s) -
Nadia Peragine,
Maria Stefania De Propris,
Stefania Intoppa,
Maria Laura Milani,
Paola Mariglia,
Francesca Romana Mauro,
Sara Raponi,
Stefano Soddu,
Antonio Cuneo,
Gian Matteo Rigolin,
Robin Foà,
Anna Guarini
Publication year - 2020
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2020.262071
Subject(s) - ibrutinib , chronic lymphocytic leukemia , rituximab , medicine , cell adhesion molecule , cancer research , leukemia , immunology , oncology , lymphoma